EDN1 and atherosclerosis: Endothelin-1 (ET-1), advanced glycation end products (AGEs), receptor for AGEs (RAGE), and cyclooxygenase-2 (COX-2) are also considered to contribute to the progression of atherosclerosis [17,18,19,20].